The Goldman Sachs Group began coverage on shares of Cricut (NASDAQ:EWTX) in a report issued on Monday morning, The Fly reports. The brokerage issued a neutral rating and a $31.00 price target on the stock.
EWTX opened at $26.76 on Monday. Cricut has a twelve month low of $23.56 and a twelve month high of $40.49.
In other news, major shareholder James E. Flynn bought 625,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 30th. The shares were purchased at an average price of $16.00 per share, with a total value of $10,000,000.00. Following the completion of the acquisition, the insider now directly owns 4,962,207 shares in the company, valued at $79,395,312. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jonathan D. Root bought 15,625 shares of the company’s stock in a transaction that occurred on Tuesday, March 30th. The shares were purchased at an average cost of $16.00 per share, for a total transaction of $250,000.00. Following the acquisition, the director now owns 15,625 shares of the company’s stock, valued at $250,000. The disclosure for this purchase can be found here.
Edgewise Therapeutics, Inc, a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders.
Further Reading: Calculating net profit and net profit margin ratio
Receive News & Ratings for Cricut Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cricut and related companies with MarketBeat.com's FREE daily email newsletter.